Hyper-progressive disease in patients with advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo)

被引：0
|
作者：
Costantini, Adrien [1 ]
Corny, Jennifer [2 ]
Fallet, Vincent [1 ]
Renet, Sophie [2 ]
Friard, Sylvie [3 ]
Chouaid, Christos [4 ]
Duchemann, Boris [5 ]
Giroux-Leprieur, Etienne [6 ]
Taillade, Laurent [7 ]
Doucet, Ludovic [8 ]
Nguenang, Marina [9 ]
Jouveshomme, Stephane [10 ]
Wislez, Marie [1 ]
Tredaniel, Jean [10 ]
Cadranel, Jacques [1 ]
机构：
[1] Hop Tenon, Serv Pneumol, Paris, France
[2] Grp Hosp Paris St Joseph, Pharm Clin, Paris, France
[3] Hop Foch, Serv Pneumol, Suresnes, France
[4] Ctr Hosp Intercommunal Creteil, Serv Pneumol, Creteil, France
[5] Hop Avicenne, Serv Oncol Med, Bobigny, France
[6] Hop Ambroise Pare, Serv Pneumol & Oncol, Boulogne Billancourt, France
[7] Hop La Pitie Salpetriere, Serv Oncol Med, Paris, France
[8] Hop St Louis, Serv Oncol Med, Paris, France
[9] Hop Bichat Claude Bernard, Serv Pneumol C, Paris, France
[10] Grp Hosp Paris St Joseph, Serv Pneumol, Paris, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA2808
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2808
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab
    Cusato, Jessica
    Genova, Carlo
    Tomasello, Cristina
    Carrega, Paolo
    Ottonello, Selene
    Pietra, Gabriella
    Mingari, Maria Cristina
    Cossu, Irene
    Rijavec, Erika
    Leggieri, Anna
    Di Perri, Giovanni
    Dal Bello, Maria Giovanna
    Coco, Simona
    Boccardo, Simona
    Ferlazzo, Guido
    Grossi, Francesco
    D'Avolio, Antonio
    CANCERS, 2019, 11 (01):
  • [22] Clinical and Plasma Biomarkers for Disease Control with Nivolumab Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC)
    Daher, Sameh
    Lawrence, Yaacov
    Dudnik, Elizabeth
    Hanovich, Ekaterina
    Urban, Damien
    Peled, Nir
    Navon, Rossie
    Leibowitz-Amit, Raya
    Hammerman, Ariel
    Battat, Erez
    Bar, Jair
    Onn, Amir
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1307 - S1307
  • [23] Nivolumab Experience in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC) in Toledo, Spain
    Martinez Moreno, E.
    Irigoyen Medina, A.
    Martinez Barroso, K.
    Borregon Rivilla, M.
    Alvarez Cabellos, R.
    Cardenas, J. D.
    Andrade Santiago, J.
    Burgueno Lorenzo, I.
    Trujillo Alba, B.
    Chacon Lopez-Muniz, J. I.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2430 - S2430
  • [24] Hyperprogressive disease in patients with non-small cell lung cancer treated with nivolumab: A case series
    Kanazu, Masaki
    Edahiro, Ryuya
    Krebe, Hiroyuki
    Nishida, Kohei
    Ishijima, Mikako
    Uenami, Takeshi
    Akazawa, Yuki
    Yano, Yukihiro
    Yamaguchi, Toshihiko
    Mori, Masahide
    THORACIC CANCER, 2018, 9 (12) : 1782 - 1787
  • [25] Nivolumab monotherapy in patients with previously treated advanced non-small cell lung cancer (NSCLC) in routine clinical practice in a Spanish center
    Mielgo, X.
    Toro, P.
    Ruiz-Gimenez, L.
    Olier, C.
    Perez, M.
    Rosero, A.
    Camara, J. C.
    Hernando, S.
    Hurtado, A.
    Jara, C.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S135 - S135
  • [26] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea.
    Park, Keunchil
    Cho, Eun Kyung
    Kang, Jin Hyoung
    Han, Ji-Youn
    Lee, Jong Seok
    Kim, Dong-Wan
    Kim, Sang-We
    Cho, Byoung Chul
    Min, Young Joo
    Lee, Ki Hyeong
    Kim, Joo-Hang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [27] Outcomes of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) in A Regional Australian Population
    Kasherman, Lawrence
    Brungs, Daniel
    Bell, Graeme
    Glasgow, Amanda L.
    Tafreshi, Ali
    Clingan, Philip
    Aghmesheh, Morteza
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 145 - 146
  • [28] Outcomes of nivolumab (NIVO)-treated patients (pts) with advanced non-small cell lung cancer (aNSCLC) in United States community oncology practice.
    Nadler, Eric
    Espirito, Janet
    Wilson, Thomas
    Gupte-Singh, Komal
    Rao, Sumati
    Korytowsky, Beata
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [29] Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC)
    Hellmann, M. D.
    Rizvi, N.
    Gettinger, S. N.
    Goldman, J.
    Chow, L. Q.
    Juergens, R.
    Borghaei, H.
    Brahmer, J.
    Shen, Y.
    Harbison, C. T.
    Nathan, F.
    Ready, N. E.
    Antonia, S. J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S632 - S633
  • [30] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
12345